AKT1 and central nervous system cancer: By combining our previous findings that PD-L1 promotes EMT of glioma cells, we speculate that PD-L1/Akt/autophagy/F-actin is a key driving force for GBM aggressiveness, which serves as a potential therapeutic target for GBM.